Intrauterine growth retardation is a risk factor for Cisapride-induced QT prolongation in preterm infants

Cardiovascular Drugs and Therapy

Volumn 18, Issue 5, 2004, Pages 371-375

  Corvaglia, Luigi ^a,b   Faldella, Giacomo ^a   Rotatori, Raffaella ^a   Lanari, Marcello ^a   Capretti, Maria Grazia ^a   Salvioli, Gian Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto Clinico di Pediatria Preventiva e Neonatologia   (Italy)

Author keywords

Cisapride; Preterms; QT corrected interval; Small for gestational age

Indexed keywords

CISAPRIDE;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; DRUG SAFETY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; GASTROESOPHAGEAL REFLUX; GROUPS BY AGE; HEART ARRHYTHMIA; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LIVER DISEASE; LOW BIRTH WEIGHT; PREMATURITY; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SMALL FOR DATE INFANT; VOMITING;

ANTI-ULCER AGENTS; BIRTH WEIGHT; CISAPRIDE; ELECTROCARDIOGRAPHY; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INTENSIVE CARE UNITS, NEONATAL; LONG QT SYNDROME; MALE;

EID: 17644399491     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-005-5061-0     Document Type: Article

References (23)

1. Enriquez A, Bolisetty S, Patole S, Garvey PA, Campbell PJ. Randomised controlled trial of Cisapride in feed intolerance in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;79:F110-P113.
2. Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnoea in premature infants. J Pediatr 2001;138:355-360.
3. Ward RM, Lemons JA, Molteni RA. Cisapride: A survey of the frequency of use and adverse events in premature newborns. Pediatrics 1999;103:469-472.
4. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996;335:290-291.
5. Lewin MB, Bryant RM, Fenrich AL, Griffa RG. Cisapride-induced long QT interval. J Pediatr 1996;128:279-281.
6. Bernardini S, Semama DS, Huet F, Sgro C, Gouyon JB. Effects of Cisapride on QTc interval in neonates. Arch Dis Child 1997;77:F241-F243.
7. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-629.
8. Tonini M, De Ponti F, Di Nucci A, Crema F. Review article: Cardiac adverse effects of gastrointestinal prokinetics [review]. Aliment Pharmacol Ther 1999;13:1585-1591.
9. Drolet B, Khalifa M, Deleau P, Hamelin BA, Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent Cisapride underlies drug-related lengthening of the QT interval. Circulation 1998;97:204-210.
10. Vandenplas Y, Belli DC, Benatar A, et al. The role of Cisapride in treatment of paediatric gastroesophageal reflux. J Pediatric Gastroent Nutr 1999;28:518-528.
11. Dubin A, Kikkert M, Mirmiran M, Ariano R. Cisapride associated with QTc prolongation in very low birth weight preterm infants. Pediatrics 2001;107:1313-1316.
12. Wang L, Feng ZP, Kondo CS, Sheldon RS, Duff HJ. Developmental changes in the delayed rectifier K channel in mouse heart. Circ Res 1996;79:79-85.
13. Wang L, Duff HG. Identification and characteristic of the delayed rectifier K current in fetal mouse ventricular myocytes. Am J Physiol 1996;270:H2088-H2093.
14. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3A in human liver: evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-634.
15. Horsmans Y. Major cytochrome P-450 families: Implications in health and liver disease. Acta Gastroenetrol Belg 1997;60:2-10.
16. Cools F, Benatar A, Bruneel E, et al. A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants. Eur J Clin Pharmacol 2003;59:17-22.
17. Bergman JW, Human DE, Moor MMA, Schulz JM. Effect of kwashiorkor on the cardiovascular system. Arch Dis Child 1988;63:1359-1362.
18. Thwaites BC, Bose M. Very low calorie diets and pre-fasting prolonged QT interval. A hidden potential danger. West Indian Med J 1992;41:169-171.
19. Fuenmayor AJ, Mora RE, Fuenmayor AC, Fuenmayor AM. QT-interval dispersion in malnourished children. Clin Cardial 1998;21:201-205.
20. Cunha DF, Cunha SF, Ferreira TP, et al. Prolonged QTc intervals on the electrocardiograms of hospitalised malnourished adults. Nutrition 2001;17:370-372.
21. Cooke RA, Chambers JB, Singh R, et al. QT interval in anorexia nervosa. Br Heart J 1994;72:69-73.
22. Widmark C, Jansson T, Lindecrantz K, Rosen KG. ECG waveform, short term heart rate variability and plasma catecholamine concentration in response to hypoxia in intrauterine growth retarded guinea-pig fetuses. J Dev Physiol 1991;15:161-163.
23. Massin MM, Withofs N, Maeyns K, Ravet F. The influence of fetal and postnatal growth on heart rate variability in young infants. Cardiology 2001;95:80-83.